Target intelligence / Profile preview

GTP cyclohydrolase 1 feedback regulatory protein (GCHFR)

Target
GCHFR
Molecular classification
Regulatory protein, Enzyme regulator, Enzyme inhibitor
01

Overview

GTP cyclohydrolase 1 feedback regulatory protein (GCHFR) is a regulatory enzyme found in humans, encoded by the GCHFR gene. Its principal role is to modulate the activity of GTP cyclohydrolase I (GCH1), the first and rate-limiting enzyme in the biosynthesis of tetrahydrobiopterin (BH4). GCHFR forms oligomeric complexes with GCH1, mediating inhibition when bound to BH4 and activation in the presence of phenylalanine. Through this metabolic-sensing mechanism, GCHFR influences phenylalanine metabolism, the synthesis of biogenic amine neurotransmitters (such as dopamine and serotonin), and the production of nitric oxide. Genetic mutations or disruptions in this pathway are implicated in diseases involving neurotransmitter metabolism, including forms of hyperphenylalaninemia and phenylketonuria. Structural studies have revealed the molecular basis of its allosteric regulation, supporting its potential as a therapeutic target in disorders where BH4 metabolism is relevant.

Other names
GCHFRGFRPHsT16933P35GTP cyclohydrolase I feedback regulatorGTP cyclohydrolase I feedback regulatory protein
02

Mechanism of action

GCHFR allosterically inhibits GTP cyclohydrolase I via BH4 binding and allosterically activates it via L-phenylalanine binding.

03

Biological functions

Regulation of tetrahydrobiopterin (BH4) biosynthesisRegulation of phenylalanine metabolismRegulation of biogenic amine neurotransmitter productionModulation of nitric oxide synthesis
04

Disease associations

Hyperphenylalaninemia (BH4-deficient, type A)PhenylketonuriaPotential roles in pain disordersPotential involvement in other neurotransmitter-related diseases
05

Safety considerations

No specific safety issues identified for direct targeting of GCHFR.Theoretical considerations may include impacts on neurotransmitter biosynthesis leading to neurological effects.Theoretical considerations may include impacts on nitric oxide synthesis leading to vascular effects.
06

Biomarkers

BH4 levelsphenylalanine levels

Beyond the preview

Go deeper on GTP cyclohydrolase 1 feedback regulatory protein (GCHFR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GTP cyclohydrolase 1 feedback regulatory protein (GCHFR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call